There is a number of things that pharmacy students can do to help their communities during the COVID-19 pandemic.
Sephin1 found to protect oligodendrocytes, axons, and myelin, as well as reduce central nervous system inflammation in multiple sclerosis.
Methods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization
Label change is part an effort to help inform proviers about balancing the serious risks of opioids with their role in pain management.
The involvement of community pharmacists is vital to reduce prescription drug abuse through the use of Electronic Prescription Drug Monitoring Programs.
The 340B program helps rural and urban safety-net health providers care for underserved patients across America every day.
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
A review of current treatment recommendations for chronic obstructive pulmonary disease with a focus on currently available medication devices.
A guide to treatment of rheumatoid arthritis, the most common chronic inflammatory joint disease.
Continuous glucose monitoring has revolutionized the way patients with diabetes can monitor their glucose.
Pharmacists can increase awareness about the value of monitoring glucose and the proper use of nonprescription blood glucose meters and continuous glucose monitors.
Transitioning infusion therapy patients from hospital outpatient or medical office settings to home care, when appropriate, can result in significant reductions in medical drug spending.
Antimicrobial stewardship programs have been around for some time. However, a tipping point has yet to be achieved where most hospitals and long-term care facilities have effective programs.
The discussion explores how Medicare's Part D smoothing program in 2025 might impact chronic lymphocytic leukemia patients’ access to and adherence to Bruton tyrosine kinase inhibitor therapies and how pharmacists can help navigate this new program. The session concludes with closing remarks.
The main goal of the Sunshine Act is to create more transparency, with the ultimate goal of reducing the marketing impact on the physicians' treatment decisions, resulting in lower health care costs. The Final Rule is on a whole new national level and the potential response from physicians must be evaluated.
Older adults are vulnerable to severe influenza-associated complications and risks, but influenza vaccines may be less effective in this population.
The inhibition of the tumor necrosis factor alpha (TNF-α) pathway and its proinflammatory processes has been central in psoriasis management.
As pharmacy practice rapidly changes, pharmacists are encountering greater opportunities to provide advanced patient care.
This study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.
Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.
According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.
Comprehensive pharmacy services would mean having the pharmacy team develop the management strategy for specialty medications used under either the medical benefit or the pharmacy benefit.
Advancements in the understanding of asthma pathophysiology has led to the discovery of defined asthma phenotypes and targeted interventions involving novel biologic therapies.